briva | 11760
Brivaracetam (Briviact®)
Keywords
BRV
| Material |
|
|
| Note |
Sampling for trough level (before the next dose). |
|
| Min. quantity | 500 µL | |
| Stability | 2 weeks / 2-8°C | |
| Duration | 2 - 6 days | |
| Frequency | 3 x per week (monday, wednesday, friday) | |
| Method | Liquid chromatography / mass spectrometry (LCMS) | |
| Price | CHF 126.00 | |
| Tariff | 126.00 TP | |
| LA position | 1069.00 | |
| Designation | Antiepileptika der SL/ALT inkl. Metaboli | |
| Executing laboratory | External laboratory |
Reference values
| Value | Sex |
|---|---|
| 0.2 - 2.0 mg/L | f+m |
| toxic:> 1.8 mg/L | f+m |
Team of consultants
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine
|
FAMH Specialist in laboratory medicine | T |
|
|
PharmD
Sarah Molteni
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
MD
Uta Deus
FMH General internal medicine, FAMH Specialist in laboratory medicine
|
FMH General internal medicine, FAMH Specialist in laboratory medicine | T |
|